life science portfolio support for investors

• alignment of relevant internal & external stakeholders, strategic leadership, resource allocation for optimal return-on-investment

• day-to-day (project)management

operation due diligence / M&A guidance

• identification and assessment of value determinants & overall valuation, scenario planning, sensitivity analysis, realistic potential

• preclinical, manufacturing & regulatory evaluation: mode-of-action, proof-of-concept, product characterisation and production validation

• clinical program assessment: efficacy, relevance of clinical data, expert endorsement, ability to address market access requirements

• competitive environment and benchmarking versus marketed and emerging products/technologies, market potential estimation